Skip to content

Author

M. Castera

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Phase II study of cabozantinib in recurrent or metastatic cervical cancer after progression on platinum-based chemotherapy (CABOCOL).

OBJECTIVE The antiangiogenic pathway is an effective target for recurrent uterine cervical carcinoma (rCC). This study evaluated the safety and efficacy of cabozantinib monotherapy for rCC. PATIENTS & METHODS This open-label phase II study (NCT04205799) enrolled patients with rCC who previously received platinum-base...

E. Coquan, R. Vion, Emeline Colomba-Blamemble et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.